Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ciska Verbaanderd
Observed names:
C. Verbaanderd,
Verbaanderd, Ciska
Observed institutions:
European Medicines Agency,
Anticancer Fund,
KU Leuven
ORCID:
0000-0003-3850-5613
Observed ORCID:
0000-0003-3850-5613
OpenAlex ID:
A5000577214
Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
2017
·
Ciska Verbaanderd
, Hannelore Maes
, et al.
·
ecancermedicalscience
·
282
PDF
ReDO_DB: the repurposing drugs in oncology database
2018
·
Pan Pantziarka
, Ciska Verbaanderd
, et al.
·
ecancermedicalscience
·
139
PDF
Repurposing Drugs in Oncology: Next Steps
2017
·
Ciska Verbaanderd
, Lydie Meheus
, et al.
·
Trends in cancer
·
88
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
2020
·
Ciska Verbaanderd
, Ilse Rooman
, et al.
·
Frontiers in Pharmacology
·
82
PDF
Repurposing drugs in oncology: From candidate selection to clinical adoption
2020
·
Pan Pantziarka
, Ciska Verbaanderd
, et al.
·
Seminars in Cancer Biology
·
75
Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research
2021
·
Ciska Verbaanderd
, Ilse Rooman
, et al.
·
Trials
·
49
PDF
Neuropathy of Trigeminal Nerve Branches After Oral and Maxillofacial Treatment
2015
·
Jimoh Olubanwo Agbaje
, Elke Van de Casteele
, et al.
·
Journal of Maxillofacial and Oral Surgery
·
42
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicines
2022
·
G. Zarkavelis
, A.L. Amylidi
, et al.
·
ESMO Open
·
26
Biomarker‐Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European Union
2023
·
Ciska Verbaanderd
, Ana Trullás Jimeno
, et al.
·
Clinical Pharmacology & Therapeutics
·
25
PDF
How to balance valuable innovation with affordable access to medicines in Belgium?
2022
·
Steven Simoens
, Khadidja Abdallah
, et al.
·
Frontiers in Pharmacology
·
22
PDF
Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective
2020
·
Stefanie Broes
, Ciska Verbaanderd
, et al.
·
Frontiers in Medicine
·
15
PDF
Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders
2021
·
Jorn Mulder
, Robin Verjans
, et al.
·
Frontiers in Medicine
·
4
PDF
Biased by design? Clinical trials and patient benefit in oncology
2019
·
Pan Pantziarka
, Ciska Verbaanderd
, et al.
·
Future Oncology
·
3
PDF
Drug repurposing in oncology: Tapping into the potential of data sharing and partnership initiatives
2020
·
Ciska Verbaanderd
Drug repurposing in oncology: Tapping into the potential of data sharing and partnership initiatives
2020
·
Ciska Verbaanderd
, Isabelle Huys
, et al.
Pcn224 - Towards Clinical Adoption of Repurposed Drugs in Oncology: Overcoming Regulatory and Market Access Barriers in Europe
2018
·
C. Verbaanderd
, I. Rooman
, et al.
·
Value in Health
Show more works
View as search
Works count:
20
Citation count:
852
H-index:
11
I10-index:
11
Year
Topic
Type